Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

1(20%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

40%

Ph phase_2

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 2Efficacy & side effects

1(33.3%)

N/ANon-phased studies

2(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(4)

Detailed Status

Completed4

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 21 (33.3%)

N/A2 (66.7%)

Trials by Status

completed480%

recruiting120%

Recent Activity

1 active trials

Showing 5 of 5

completednot_applicable

Infraorbital-Infratrochlear Block vs Sphenopalatine Ganglion Block for Postoperative Analgesia in Septorhinoplasty.

NCT07345039

recruitingphase_2

Transnasal Sphenopalatine Ganglion Block for Treatment of Acute Subarachnoid Hemorrhage Associated Headache

NCT06621329

completed

Clinical Trials (5)

Showing 5 of 5 trials

NCT07345039Not Applicable

Infraorbital-Infratrochlear Block vs Sphenopalatine Ganglion Block for Postoperative Analgesia in Septorhinoplasty.

Completed

NCT06621329Phase 2

Transnasal Sphenopalatine Ganglion Block for Treatment of Acute Subarachnoid Hemorrhage Associated Headache

Recruiting

NCT06496841

Transnasal Versus Suprazygomatic SPG Block in Persistant Idiopathic Facial Pain

Completed

NCT06243874Not Applicable

Comparison of Occipital Nerve and Sphenopalatine Ganglion Blockade

Completed

NCT04479176

Comparison of Two Methods of Transnasal Sphenopalatine Ganglion Block

Completed

All 5 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 5